Enterome Enters Collaboration With Major Cancer Center Focused on New Microbiome-derived Immunotherapies
ENTEROME, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the key functional and molecular interactions between the gut microbiome and the human body to develop targeted therapeutics, has entered into a research collaboration with Memorial Sloan Kettering Cancer Center